Persistent and temporary depressive symptoms were linked to youth marijuana use

State- and Trait-Level Depressive Symptoms and Marijuana Use Among Urban Youth.

Western journal of nursing research β€’ β€’ Highly Relevant
πŸ€–

AI Summary

This observational secondary analysis asked whether persistent or temporary changes in depressive symptoms were associated with marijuana-use frequency among urban youth. It analyzed 2,807 observations from 1,516 youth in 1,456 households, using a model that accounted for observations within youth and families and adjusted for several demographic factors. The study distinguished each youth’s average depressive symptoms over time from changes around that average.

Both measures were associated with more frequent use: average, or trait-level, symptoms had an adjusted odds ratio of 5.31, while temporary, or state-level, elevations had an adjusted odds ratio of 2.70. The authors report that trait-level symptoms represented the larger association, while acute elevations were also linked to increased use. These findings describe associations, not evidence that depressive symptoms cause marijuana use or that screening prevents it. As an abstract-based summary, the main limitation is that this secondary observational analysis cannot establish causation or show whether the proposed interventions are effective.

πŸ’‘ Key Findings

1
Higher trait-level depressive symptoms were associated with more frequent marijuana use (adjusted odds ratio 5.31; 95% CI, 2.82–10.00).
High
90%
2
Higher-than-usual state-level depressive symptoms were also associated with more frequent use (adjusted odds ratio 2.70; 95% CI, 1.44–5.04).
High
90%
3
The abstract reports that by age 18, up-to-twice-weekly use among youth with high trait-level symptoms reached 13.3% for males and 7.3% for females; these are reported use rates, not evidence of causation.
High
90%

πŸ“„ Original Abstract

BACKGROUND: Marijuana is the most used illicit substance among youth, yet whether risk reflects stable or fluctuating depressive symptoms is unclear. OBJECTIVE: This study examined whether state-level and trait-level depressive symptoms affect marijuana use, informing nurse-led screening and prevention. METHODS: Guided by ecological systems theory, this secondary analysis of the Adolescent Health and Development in Context study used an ordered logistic regression model. Trait-level symptoms were each youth's average over time; state-level symptoms, deviations from the average. The model adjusted for caregiver education, sex, race, and age across 3 levels: observations within youth within families. RESULTS: We analyzed 2807 observations from 1516 youth, from 1456 households trait-level depressive symptoms (adjusted odds ratio [aOR] = 5.31; 95% confidence interval [CI], 2.82-10.00) and state-level symptoms (aOR = 2.70; 95% CI, 1.44-5.04) predicted higher frequency use. Male sex (aOR = 2.04; 95% CI, 1.16-3.60) and age (aOR = 1.79; 95% CI, 1.48-2.16) were significant. At age 12, any use was negligible; by age 18, up-to-twice-weekly use reached 13.3% for males and 7.3% for females at high trait-level symptoms. CONCLUSIONS: Trait-level symptoms carry the larger, chronic risk, while state-level elevations trigger additional short-term increase in use; interventions during acute distress may prevent escalation. Nurses can use depression screening to prevent use and flag underlying depression.

Explore More Research

Stay informed about the latest cannabis science.

Your stash, decoded.